{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:10:34Z","timestamp":1790874634970,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the burden and temporal trends of chronic kidney disease (CKD) attributable to hypertension in China, Japan, and the Republic of Korea from 1990 to 2023 using Global Burden of Disease (GBD) 2023 data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Age-standardized incidence, mortality, and DALYs rates (ASIR, ASMR, and ASDR [age-standardized DALYs rate], respectively) and estimated annual percentage change (EAPC) were calculated for the three countries and globally. Segmented regression identified phase-specific inflections in incidence trends, decomposition analysis partitioned absolute changes into population growth, aging, and epidemiological contributions, and age-period-cohort (APC) analysis characterized drivers of ASDR. Attributable fractions ranked modifiable risk factors for cause-specific mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2023, Japan had the highest ASIR (37.43 per 100,000) while China had the lowest (17.50 per 100,000); all three countries fell below the global ASMR and ASDR. China and the Republic of Korea achieved significant declines across all standardized rates, whereas Japan\u2019s near-null overall incidence trend concealed a marked late-period acceleration (2017\u20132023 APC = 0.86%). Globally, ASMR and ASDR rose significantly. Burden concentrated in adults aged 75\u201379\u00a0years and was consistently higher in males globally. Epidemiological change strongly offset demographic pressures in all three countries, and descriptive APC examination identified protective period- and cohort-related patterns in China and the Republic of Korea but an emerging adverse cohort-related pattern in Japan. High systolic blood pressure dominated attributable mortality (67%\u201389% in 2023), with the contribution of high body-mass index rising substantially over the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The burden of hypertension-attributed CKD has followed markedly divergent trajectories across East Asia, with Japan bearing a disproportionately high and recently accelerating incidence, underscoring the need for age-targeted screening and country-specific prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-026-05377-w","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:15:21Z","timestamp":1788750921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic kidney disease due to hypertension in China, Japan, and the Republic of Korea: trends from the Global Burden of Disease Study 1990\u20132023"],"prefix":"10.1007","author":[{"given":"Bo","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"10518","key":"5377_CR1","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","volume":"406","author":"GBD 2023 Chronic Kidney Disease Collaborators","year":"2025","unstructured":"GBD 2023 Chronic Kidney Disease Collaborators (2025) Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406(10518):2461\u20132482. https:\/\/doi.org\/10.1016\/S0140-6736(25)01853-7","journal-title":"Lancet"},{"issue":"10513","key":"5377_CR2","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","author":"GBD 2023 Disease and Injury and Risk Factor Collaborators","year":"2025","unstructured":"GBD 2023 Disease and Injury and Risk Factor Collaborators (2025) Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406(10513):1873\u20131922. https:\/\/doi.org\/10.1016\/S0140-6736(25)01637-X","journal-title":"Lancet"},{"issue":"1","key":"5377_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04386-8","volume":"26","author":"Y He","year":"1990","unstructured":"He Y, Tang W, Chen J, Tang J, Zheng Y, Wang X et al (1990) Global burden of chronic kidney disease due to hypertension (1990-2021): a systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study. BMC Nephrol 26(1):448. https:\/\/doi.org\/10.1186\/s12882-025-04386-8","journal-title":"BMC Nephrol"},{"issue":"4","key":"5377_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J (2020) The global epidemiology of hypertension. Nat Rev Nephrol 16(4):223\u2013237. https:\/\/doi.org\/10.1038\/s41581-019-0244-2","journal-title":"Nat Rev Nephrol"},{"issue":"10304","key":"5377_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2021) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398(10304):957\u2013980. https:\/\/doi.org\/10.1016\/S0140-6736(21)01330-1","journal-title":"Lancet"},{"key":"5377_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1503837","volume":"13","author":"Y Lai","year":"1990","unstructured":"Lai Y, Long H, Liang Z, Wu C, Wu L, Liu C et al (1990) Global burden and risk factors of chronic kidney disease due to hypertension in adults aged 20 plus years, 1990-2021. Front Public Health 13:1503837. https:\/\/doi.org\/10.3389\/fpubh.2025.1503837","journal-title":"Front Public Health"},{"issue":"1","key":"5377_CR7","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1472","volume":"20","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Ji Z, Hou J, Yang J, Wu H, Zhang L (2025) Burden of hypertensive heart disease and its risk factors in East Asia, 1990-2021: findings from the Global Burden of Disease Study 2021. Glob Heart 20(1):82. https:\/\/doi.org\/10.5334\/gh.1472","journal-title":"Glob Heart"},{"key":"5377_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101138","volume":"49","author":"RSJ Goh","year":"2024","unstructured":"Goh RSJ, Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Kueh MTW et al (2024) The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions. Lancet Reg Health West Pac 49:101138. https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101138","journal-title":"Lancet Reg Health West Pac"},{"key":"5377_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1080682","volume":"10","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Ma J, Zhu J, Liu Y, Ren W, Zhang S et al (2023) Deaths and disability-adjusted life years of hypertension in China, South Korea, and Japan: a trend over the past 29 years. Front Cardiovasc Med 10:1080682. https:\/\/doi.org\/10.3389\/fcvm.2023.1080682","journal-title":"Front Cardiovasc Med"},{"key":"5377_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1510091","volume":"13","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhu J, Zhou J (2025) Disease burden and attributable risk factors of major depressive disorder in China, Japan, and South Korea from 1990 to 2021 and its prediction to 2035. Front Public Health 13:1510091. https:\/\/doi.org\/10.3389\/fpubh.2025.1510091","journal-title":"Front Public Health"},{"issue":"23","key":"5377_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70656","volume":"14","author":"T Guo","year":"1990","unstructured":"Guo T, Zhu W, Hui Y, Wang Y, Zhou T, Shen W et al (1990) The burden of pancreatic cancer in five East Asian countries from 1990 to 2021 and its prediction up to 2036: a systemic analysis of the Global Burden of Diseases Study 2021. Cancer Med 14(23):e70656. https:\/\/doi.org\/10.1002\/cam4.70656","journal-title":"Cancer Med"},{"issue":"7","key":"5377_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322787","volume":"20","author":"J Luo","year":"2025","unstructured":"Luo J, Zhang Y, Luo Z (2025) Assessing the global burden of Type 2 diabetes in women of reproductive age. PLoS ONE 20(7):0322787. https:\/\/doi.org\/10.1371\/journal.pone.0322787","journal-title":"PLoS ONE"},{"issue":"1","key":"5377_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-04484-9","volume":"26","author":"X Huang","year":"2026","unstructured":"Huang X, Sang Z, Shi Z, Li J, Geng M, Cao X (2026) Long-term trends in disease burden of esophageal cancer in China and the forecast until 2050. BMC Gastroenterol 26(1):36. https:\/\/doi.org\/10.1186\/s12876-025-04484-9","journal-title":"BMC Gastroenterol"},{"issue":"19","key":"5377_CR14","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1002\/sim.1545","volume":"22","author":"VM Muggeo","year":"2003","unstructured":"Muggeo VM (2003) Estimating regression models with unknown break-points. Stat Med 22(19):3055\u20133071. https:\/\/doi.org\/10.1002\/sim.1545","journal-title":"Stat Med"},{"key":"5377_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2026.116825","volume":"254","author":"A Alyahya","year":"1999","unstructured":"Alyahya A, Albegamy Y, Albalawi MA, Elkarouri A, Alanazi S, Alshehri L et al (1999) Trends in mortality from high-risk surgical procedures: national burden of transplants, implants, and organ removal from 1999 to 2024 in United States. Am J Surg 254:116825. https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116825","journal-title":"Am J Surg"},{"key":"5377_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1623789","volume":"15","author":"T Cui","year":"2025","unstructured":"Cui T, Guan C, Song K, Yu J (2025) Global trends and forecasts of nonalcoholic steatohepatitis causing liver cancer incidence and deaths. Front Oncol 15:1623789. https:\/\/doi.org\/10.3389\/fonc.2025.1623789","journal-title":"Front Oncol"},{"issue":"2","key":"5377_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-005383","volume":"11","author":"K Tang","year":"1990","unstructured":"Tang K, Zhu L, Shan S, Luo Z, Zhou J, Ying J et al (1990) Global, regional and national trends in the epidemiology of rheumatoid arthritis from 1990 to 2021: an age-period-cohort effect analysis of the global burden of disease study 2021. RMD Open 11(2):e005383. https:\/\/doi.org\/10.1136\/rmdopen-2024-005383","journal-title":"RMD Open"},{"issue":"9380","key":"5377_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0140-6736(03)13968-2","volume":"362","author":"M Ezzati","year":"2003","unstructured":"Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ (2003) Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 362(9380):271\u2013280. https:\/\/doi.org\/10.1016\/s0140-6736(03)13968-2","journal-title":"Lancet"},{"issue":"11","key":"5377_CR19","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143(11):1157\u20131172. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"key":"5377_CR20","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s11255-025-04924-1","volume":"58","author":"L Kumar","year":"1999","unstructured":"Kumar L, Mustafa I, Kumar N, Fasih A, Warisha S, Khan L et al (1999) Temporal trends in mortality attributable to atrial fibrillation among adults with acute renal failure in the United States, 1999\u20132024. Int Urol Nephrol 58:2269\u20132281. https:\/\/doi.org\/10.1007\/s11255-025-04924-1","journal-title":"Int Urol Nephrol"},{"key":"5377_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s12872-025-05036-5","volume":"25","author":"S Rani","year":"2025","unstructured":"Rani S, Kumar L, Ali SME, Ashraf S, Bhimani S, Kumar S et al (2025) Trends in United States mortality among patients with atrial fibrillation\/flutter related heart failure (1999\u20132024). BMC Cardiovasc Disord 25:558. https:\/\/doi.org\/10.1186\/s12872-025-05036-5","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"5377_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s10157-024-02570-y","volume":"29","author":"A Kobayashi","year":"2025","unstructured":"Kobayashi A, Hirano K, Okuda T, Ikenoue T, Yokoo T, Fukuma S (2025) Estimating the prevalence of chronic kidney disease in the older population using health screening data in Japan. Clin Exp Nephrol 29(3):276\u2013282. https:\/\/doi.org\/10.1007\/s10157-024-02570-y","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"5377_CR23","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1038\/s41440-025-02331-8","volume":"48","author":"Y Ohya","year":"2025","unstructured":"Ohya Y, Sakima A, Arima H, Fukami A, Furuhashi M, Ishida M et al (2025) Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025). Hypertens Res 48(10):2500\u20132511. https:\/\/doi.org\/10.1038\/s41440-025-02331-8","journal-title":"Hypertens Res"},{"key":"5377_CR24","doi-asserted-by":"publisher","DOI":"10.5646\/ch.2025.31.e11","volume":"31","author":"HC Kim","year":"2024","unstructured":"Kim HC, Lee H, Lee HH, Ahn SV, Lee JM, Cheon DY et al (2024) Korea Hypertension Fact Sheet 2024: nationwide population-based analysis with a focus on young adults. Clin Hypertens 31:11. https:\/\/doi.org\/10.5646\/ch.2025.31.e11","journal-title":"Clin Hypertens"},{"issue":"1","key":"5377_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-024-00262-z","volume":"30","author":"HC Kim","year":"2023","unstructured":"Kim HC, Lee H, Lee HH, Son D, Cho M, Shin S et al (2023) Korea Hypertension Fact Sheet 2023: analysis of nationwide population-based data with a particular focus on hypertension in special populations. Clin Hypertens 30(1):7. https:\/\/doi.org\/10.1186\/s40885-024-00262-z","journal-title":"Clin Hypertens"},{"issue":"8","key":"5377_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jch.70123","volume":"27","author":"Y Xin","year":"2025","unstructured":"Xin Y, Xu J, Li Z, Yin X, Wang T, Wu B et al (2025) Evaluation of population-based sodium reduction strategies in China: protocol for a study using a combined quantitative and qualitative approach. J Clin Hypertens (Greenwich) 27(8):70123. https:\/\/doi.org\/10.1111\/jch.70123","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"5377_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000001083","author":"M Ahmed","year":"2025","unstructured":"Ahmed M, Hasan M, Kumar S, Ahmed S, Zafar MNU, Kumar L et al (2025) Trends and forecast of heart failure-related deaths in US chronic obstructive pulmonary disease patients (1999\u20132030). Cardiol Rev. https:\/\/doi.org\/10.1097\/CRD.0000000000001083","journal-title":"Cardiol Rev"},{"key":"5377_CR28","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1007\/s11255-025-04490-6","volume":"57","author":"L Kumar","year":"1999","unstructured":"Kumar L, Ali T, Iqbal F, Ahmed M, Azeem B (1999) Unveiling trends in urinary tract cancer mortality among older adults in the United States (1999\u20132022): a CDC WONDER perspective. Int Urol Nephrol 57:3151\u20133161. https:\/\/doi.org\/10.1007\/s11255-025-04490-6","journal-title":"Int Urol Nephrol"},{"key":"5377_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-04664-1","volume":"25","author":"Y Ansari","year":"1999","unstructured":"Ansari Y, Raja A, Raja S, Ali SME, Ali F, Noor I et al (1999) Investigating mortality trends and disparities in tricuspid valve disorder: a U.S. nationwide study from 1999 to 2023. BMC Cardiovasc Disord 25:208. https:\/\/doi.org\/10.1186\/s12872-025-04664-1","journal-title":"BMC Cardiovasc Disord"},{"issue":"26","key":"5377_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000049403","volume":"105","author":"SH Shahab","year":"2026","unstructured":"Shahab SH, Javaid MH, Masood HG, Maheshwari S, Ahmed M, Zahid M et al (2026) Burden of chronic kidney disease due to type 2 diabetes mellitus in Asia: a retrospective analysis. Medicine (Baltimore) 105(26):e49403. https:\/\/doi.org\/10.1097\/MD.0000000000049403","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"5377_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70084","volume":"17","author":"Y Wang","year":"1990","unstructured":"Wang Y, Gu S, Xie Z, Xu Z, He W, Chen Y et al (1990) Trends and disparities in the burden of chronic kidney disease due to type 2 diabetes in China from 1990 to 2021: a population-based study. J Diabetes 17(4):70084. https:\/\/doi.org\/10.1111\/1753-0407.70084","journal-title":"J Diabetes"},{"key":"5377_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101776","volume":"68","author":"G He","year":"2026","unstructured":"He G, Liu J, Lin Y, Qi J, Hu J, Yin P et al (2026) Chronic kidney disease burden from 1990 to 2023 in China: national and provincial insights from the Global Burden of Diseases study 2023. Lancet Reg Health West Pac 68:101776. https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101776","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"5377_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.kint.2024.08.038","volume":"107","author":"S Steiger","year":"2025","unstructured":"Steiger S, Li L, Bruchfeld A, Stevens KI, Moran SM, Floege J et al (2025) Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication. Kidney Int 107(1):51\u201367. https:\/\/doi.org\/10.1016\/j.kint.2024.08.038","journal-title":"Kidney Int"},{"issue":"2","key":"5377_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020373","volume":"13","author":"Y Okawa","year":"2025","unstructured":"Okawa Y, Mitsuhashi T, Tsuda T (2025) The Asia-Pacific body mass index classification and new-onset chronic kidney disease in non-diabetic Japanese adults: a community-based longitudinal study from 1998 to 2023. Biomedicines 13(2):373. https:\/\/doi.org\/10.3390\/biomedicines13020373","journal-title":"Biomedicines"},{"key":"5377_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1611227","volume":"12","author":"H Tan","year":"1990","unstructured":"Tan H, Liu Z, Zhang Y, Yang K, Zeng Y, Li G et al (1990) Global burden and trends of high BMI-attributable chronic kidney disease: a comprehensive analysis from 1990 to 2021 and projections to 2035. Front Nutr 12:1611227. https:\/\/doi.org\/10.3389\/fnut.2025.1611227","journal-title":"Front Nutr"},{"issue":"10","key":"5377_CR36","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1080\/09603123.2025.2461700","volume":"35","author":"L Qiao","year":"1990","unstructured":"Qiao L, Li M, Wen X, Deng F, Hou X, Zou Q et al (1990) Epidemiological trends in the burden of chronic kidney disease due to lead exposure in China from 1990 to 2021 compared to global, and projections until 2050. Int J Environ Health Res 35(10):2795\u20132806. https:\/\/doi.org\/10.1080\/09603123.2025.2461700","journal-title":"Int J Environ Health Res"},{"issue":"2","key":"5377_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.kint.2024.04.021","volume":"106","author":"XQ Lao","year":"2024","unstructured":"Lao XQ, Bo Y, Chen D, Zhang K, Szeto CC (2024) Environmental pollution to kidney disease: an updated review of current knowledge and future directions. Kidney Int 106(2):214\u2013225. https:\/\/doi.org\/10.1016\/j.kint.2024.04.021","journal-title":"Kidney Int"},{"issue":"8","key":"5377_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2024.100851","volume":"6","author":"M Madero","year":"2024","unstructured":"Madero M, Chertow GM, Mark PB (2024) SGLT2 inhibitor use in chronic kidney disease: supporting cardiovascular, kidney, and metabolic health. Kidney Med 6(8):100851. https:\/\/doi.org\/10.1016\/j.xkme.2024.100851","journal-title":"Kidney Med"},{"key":"5377_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000005463","author":"A Altamimi","year":"2026","unstructured":"Altamimi A, Dahi AM, ALJohani YS, Alharbi W, Alharbi AS, Aldousari A et al (2026) Mapping the national burden of cellulitis and related conditions in the United States, 1999\u20132024: a retrospective cohort analysis. Ann Med Surg (Lond). https:\/\/doi.org\/10.1097\/MS9.0000000000005463","journal-title":"Ann Med Surg (Lond)"},{"key":"5377_CR40","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1097\/MS9.0000000000004960","volume":"88","author":"S Kumar","year":"2026","unstructured":"Kumar S, Zulfiqar R, Khan S, Malik W, Rehman A, Arshia F et al (2026) Twenty-six-year trends in U.S. mortality among older adults with coexisting chronic kidney disease and atrial fibrillation\/flutter. Ann Med Surg (Lond) 88:3325\u20133334. https:\/\/doi.org\/10.1097\/MS9.0000000000004960","journal-title":"Ann Med Surg (Lond)"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05377-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:01:42Z","timestamp":1790834502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05377-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":40,"alternative-id":["5377"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05377-w","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"25 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a secondary analysis of publicly available, aggregate, de-identified data from the GBD 2023 database. As no individual-level patient data were accessed, ethical approval and informed consent were not required.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}}]}}